NEW YORK (GenomeWeb News) – A consortium of European research partners will use €9.5 million ($12.3 million) from the EU to trawl the trenches of the deep seas in search of organisms that could be used to develop bioactive compounds for treating diseases and for nutritional and cosmetic applications.

Led by researchers at the University of Aberdeen and the University of Leuven, the 24 PharmSea initiative partners from 14 countries will collect and screen mud and sediment samples from deep oceanic trenches to discover those compounds, KU Leuven said today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.